FDAnews
www.fdanews.com/articles/133759-recalls-trim-900-million-from-j-38-j-8217-s-2010-sales

Recalls Trim $900 Million From J&J’s 2010 Sales

January 26, 2011
Johnson & Johnson’s (J&J) string of consumer product recalls cost the company $900 million in sales last year, and more recalls are possible as the company begins scrutinizing external manufacturers. J&J subsidiary McNeil Consumer Healthcare’s OTC product recalls, coupled with the suspension of production at its Fort Washington, Pa., plant, cost the company about $300 million in fourth quarter sales and about $900 million in total year sales, Louise Mehrotra, vice president of investor relations, said during a conference call Tuesday. Net earnings were $1.9 billion for the quarter compared with $2.2 billion for the same period in 2009.
Drug Industry Daily